Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18,578,488
-
Total 13F shares
-
1,686,443
-
Share change
-
+891,190
-
Total reported value
-
$3,541,351
-
Price per share
-
$2.10
-
Number of holders
-
13
-
Value change
-
+$1,994,377
-
Number of buys
-
10
-
Number of sells
-
4
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q1 2023
As of 31 Mar 2023,
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,686,443 shares.
The largest 10 holders included
Balyasny Asset Management L.P., Nantahala Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CAPTRUST FINANCIAL ADVISORS, TANDEM CAPITAL MANAGEMENT CORP /ADV, TWO SIGMA ADVISERS, LP, Oxbow Advisors, LLC, and Squarepoint Ops LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.